Karyopharm’s stock is traded on the NASDAQ global market under the symbol KPTI. Karyopharm’s initial public offering (IPO) occurred in November 2013. Our CUSIP number is 48576U 106.
We are incorporated in Delaware.
Our headquarters are located at:
85 Wells Ave, 2nd floor, Newton, MA 02459
Shares may be purchased through a financial services provider of your choice. Karyopharm does not have a direct stock purchase plan.
Currently Karyopharm does not offer a dividend or stock reinvestment plan.
Computershare Trust Company, Inc.
P.O. Box 43078
Providence, RI 02940
1-800-962-4284 (from the US, Canada, Puerto Rico)
You must contact our transfer agent. They can look up your records and make any necessary adjustments. There is a fee involved for replacing lost certificates.
Ernst & Young LLP
You can request Karyopharm Investor materials by sending an email to email@example.com or on our website.